Lactobacillus reuteri DSM 17938 and Reduced Interleukin-6 Levels

Time to effect

Median: 6 weeks · IQR 6 weeks–6 weeks · Range 6 weeks–6 weeks — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
The probiotic compounds investigated in this study did not seem to affect IBS-D patients' gut barrier function, but showed potential anti-inflammatory and symptom-improving properties, which need to be confirmed in larger study cohorts.
from: The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone

1 of 1 paper

The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT.